MEDIGROUP
Part of the group
16 companies in 4 countries
Timeline
42 events since 2010Board
Capital
Filings
Financial
Establishments
Address
Other
201020122014201620182020202220242026
The 2026 accounts are due by 31-07-2027.
2026
New statutory auditor appointed, resigned · General meeting of 24-06-20263 points ▸
- General meeting, 24-06-2026
- Auditor resignation,
- Auditor appointment,
Annual accounts 2025 filed NBBabbreviated format · 25 days before the deadline
2025
Registered in the Peppol Directory Reachable for e-invoices through 0208:0826773857
1 director appointed, 2 resignations and resign · and act as permanent representatives · appointed · General meeting of 29-09-20258 points ▸
- General meeting, 29-09-2025
- Director resignation,
- Director resignation,
- Permanent representative,
- Permanent representative,
- Director discharge,
- Director discharge,
- Director appointment,
- The deed holds 1 more point.
3 directors reappointed, and act as permanent representatives · , and · General meeting of 30-06-20257 points ▸
- General meeting, 30-06-2025
- Permanent representative,
- Permanent representative,
- Permanent representative,
- Director reappointment,
- Director reappointment,
- Director reappointment,
Annual accounts 2024 filed PDFabbreviated format · 22 days before the deadline
2024
1 director appointed, 1 resignation, 1 statutory auditor reappointed reappointed as statutory auditor · resigns · , and act as permanent representatives · General meeting of 02-07-20248 points ▸
- General meeting, 28-06-2024
- Auditor reappointment, (statutory auditor)
- General meeting, 02-07-2024
- Director resignation,
- Permanent representative,
- Director appointment,
- Permanent representative,
- Permanent representative,
- The deed holds 1 more point.
Annual accounts 2023 filed PDFabbreviated format · 26 days before the deadline
2023
Annual accounts 2022 filed PDFabbreviated format · 8 days late
2022
New day-to-day manager appointed, resigned · and act as permanent representatives · General meeting of 29-08-20228 points ▸
- General meeting, 29-08-2022
- Director resignation,
- Director appointment,
- Permanent representative,
- Permanent representative,
- Board meeting, 29-08-2022
- Director resignation, (day-to-day manager)
- Director appointment, (day-to-day manager)
Annual accounts 2021 filed PDFabbreviated format · 26 days before the deadline
2021
Back to profit net €39.3m The net result is €39.3m, after one loss-making year.
Liquidity more than 17 times current ratio 12.29 The current ratio rises from 0.69 to 12.29. Short-term debt falls from €33.4m to €2.6m.
Equity above €25m equity €41.3m ▲1,989% Equity rises from €2.0m to €41.3m.
reappointed as statutory auditor acts as permanent representative · General meeting of 24-08-20213 points ▸
- General meeting, 24-08-2021
- Auditor reappointment, (statutory auditor)
- Permanent representative,
Annual accounts 2020 filed PDFabbreviated format · 40 days late
2020
Demerger: Alter Pharma splits off to MedigroupCapital increase of €16,040.04 to €9,068,159.28 · The capital rose from €9,052,119.24 to €9,068,159.28, with 31,423 new shares · General meeting of 30-06-20204 points ▸
- General meeting, 30-06-2020
- Accounting effect, 01-01-2020
- Capital increase, €16,040.04
- Capital, €9,068,159.28, 936,635 shares
- The deed holds 10 more points.
Annual accounts 2019 filed PDFabbreviated format · 17 days before the deadline
- Board meeting, 13-05-2020, mentioned twice in the deed
- Capital, €9,052,119.24, 905,212 shares
- Accounting effect, 01-01-2020
- The deed holds 10 more points.
3 directors appointed, 2 resignations (day-to-day manager) and Alter Pharma NV resign · , , and act as permanent representatives · (day-to-day manager), and appointed · General meeting of 12-02-202014 points ▸
- General meeting, 31-01-2020
- Director resignation,
- Permanent representative,
- Director appointment,
- Board meeting, 31-01-2020
- Director resignation, (day-to-day manager)
- Director appointment, (day-to-day manager)
- General meeting, 12-02-2020
- Director resignation, Alter Pharma NV
- Permanent representative,
- Director appointment,
- Director appointment,
- Permanent representative,
- Permanent representative,
- The deed holds 1 more point.
2019
Annual accounts 2018 filed PDFfull format · 22 days before the deadline
2018
Back to profit net €1,036 The net result is €1,036, after 8 loss-making years.
1 statutory auditor appointed, 1 director appointed, 1 resignation, 1 resignation (statutory auditor) and resign · , , and act as permanent representatives · (statutory auditor) and Alter Pharma appointed · General meeting of 21-11-201811 points ▸
- General meeting, 21-11-2018
- Auditor resignation, (statutory auditor)
- Permanent representative,
- Director discharge, (statutory auditor)
- Auditor appointment, (statutory auditor)
- Permanent representative,
- Director resignation,
- Permanent representative,
- Director discharge,
- Director appointment, Alter Pharma
- Permanent representative,
- The deed holds 3 more points.
Annual accounts 2018 filed PDFfull format · 6 days before the deadline
Liquidity more than doubled current ratio 2.27 The current ratio rises from 0.91 to 2.27. Short-term debt falls from €21.2m to €9.1m.
Amendment of the articlesGeneral meeting of 19-12-20171 point ▸
- General meeting, 19-12-2017
- The deed holds 1 more point.
General meeting of 17-12-20171 point ▸
- General meeting, 17-12-2017
2017
Annual accounts 2017 filed PDFfull format · 50 days late
1 statutory auditor reappointed (statutory auditor) · and act as permanent representatives · General meeting of 30-09-20164 points ▸
- General meeting, 30-09-2016
- Auditor reappointment, (statutory auditor)
- Permanent representative,
- Permanent representative,
reappointed as director acts as permanent representative · General meeting of 13-06-20173 points ▸
- General meeting, 13-06-2017
- Director reappointment,
- Permanent representative,
2016
New managing director appointed, resigned · acts as permanent representative · General meeting of 25-09-20155 points ▸
- General meeting, 25-09-2015
- Director appointment, (managing director)
- Permanent representative,
- Board meeting, 01-09-2015
- Director resignation, (managing director)
Annual accounts 2016 filed PDFfull format · 7 days before the deadline
2015
Annual accounts 2015 filed PDFfull format · 11 days before the deadline
appointed as statutory auditor acts as permanent representative · General meeting of 27-09-20133 points ▸
- General meeting, 27-09-2013
- Auditor appointment, (statutory auditor)
- Permanent representative,
Weakest financial year net -€6.2m The net result drops to -€6.2m, the lowest from 2011 to 2025. It recovers the following year.
2014
Annual accounts 2014 filed PDFfull format · 3 days before the deadline
2013
Annual accounts 2013 filed PDFfull format · 43 days late
2012
Annual accounts 2012 filed PDFabbreviated format · 36 days late
Annual accounts 2011 filed PDFabbreviated format · 85 days late
2011
Registered office moved from Sint-Pieters-Leeuw to AnderlechtThe registered office moved from Bergensesteenweg 709, 1600 Sint-Pieters-Leeuw to Marie Curie Square 50 te 1070 Anderlecht · Board meeting of 01-10-20112 points ▸
- Board meeting, 01-10-2011
- Registered-office move, Marie Curie Square 50 te 1070 Anderlecht
2010
Incorporation PDFpublished on 22-06-2010
First establishment At the time the registered office was still in Sint-Pieters-Leeuw, Bergensesteenweg 709.
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
MEDIGROUP was incorporated on 18 June 2010.1 The registered office was moved to Anderlecht in 2011.2 In 2020 the capital was increased by €16,040 to €9.1m.3 The board currently has 2 members. has served longest, since 2025.4 Total assets fell from €35.3m in 2020 to €30.2m in 2025 and headcount from 13.4 to 14.1 full-time equivalents.5